SCHEMBL3564129

SCHEMBL3564129

CCN1CCN(Cc2cc(C(=O)Nc3ccc(C)c(Nc4nccc(-c5cncnc5)n4)c3)ccc2C(F)(F)F)CC1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 20/20 0.81
BCR P11274 14/20 0.81
LYN P07948 8/20 0.81
PDGFRB P09619 4/20 0.71
LCK P06239 2/20 0.71
FYN P06241 2/20 0.71
BRAF P15056 2/20 0.71
NQO2 P16083 2/20 0.71
ABL2 P42684 2/20 0.71
FRK P42685 2/20 0.71
IRAK1 P51617 2/20 0.71
DDR1 Q08345 2/20 0.71
MAPK11 Q15759 2/20 0.71
MAPK14 Q16539 2/20 0.71
DDR2 Q16832 2/20 0.71
PIP4K2C Q8TBX8 2/20 0.71
MAP3K20 Q9NYL2 2/20 0.71
RIPK2 O43353 1/20 0.71
RET P07949 1/20 0.71
ARAF P10398 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3566953 0.95 ABL1 (0.90) ABL1BCRLYNPDGFRBLCK
Hydrochloric Acid SCHEMBL3569831 0.94 ABL1 (0.88) ABL1BCRLYNPDGFRBLCK
SCHEMBL3561413 0.90 ABL1 (1.00) ABL1BCRLYNPDGFRBLCK
Hydrochloric Acid SCHEMBL3565463 0.89 ABL1 (0.99) ABL1BCRLYNPDGFRBLCK
SCHEMBL3561756 0.88 ABL1 (0.90) ABL1BCRLYNPDGFRBLCK
SCHEMBL3562382 0.88 ABL1 (0.90) ABL1BCRLYNPDGFRBLCK
Hydrochloric Acid SCHEMBL3558323 0.88 ABL1 (0.89) ABL1BCRLYNPDGFRBLCK
Hydrochloric Acid SCHEMBL3661321 0.88 ABL1 (0.89) ABL1BCRLYNPDGFRBLCK
SCHEMBL3560129 0.88 ABL1 (0.86) ABL1BCRLYNPDGFRBLCK
SCHEMBL3564696 0.87 ABL1 (0.76) ABL1BCRLYNPDGFRBLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7728131-B2 3-difluoromethyl-4-(4-methylpiperazin-1-ylmethyl)-N-{4-methyl-3-[4-(5-pyrimidinyl)pyrimidin-2-ylamino]phenyl}benzamide, having excellent tyrosine kinase inhibitory activity, used as therapeutic agent for leukemia NIPPON SHINYAKU CO., LTD. (JP) 2010-06-01 US claimed